Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy

NCT04937062 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT04937062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04937062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy
Lead sponsor
Weill Medical College of Cornell University
Phase
Phase 1
Overall status
Active, not recruiting
Start date
March 1, 2021
Completion date
December 31, 2026
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

developmental and epileptic encephalopathy, stxbp1 encephalopathy with epilepsy, slc6a1 neurodevelopmental disorder